Cancer Failures

I. When binding overloads capacity

NEPA is the lead specimen because review duties now compete with deployment capacity for major federal projects. The 1970 National Environmental Policy Act required federal agencies to assess environmental impacts before major actions; implementing regulations, case law, and procedural accretion have since turned environmental review into a multi-year, multi-volume undertaking with extensive consultation, alternatives analysis, public comment, and litigation exposure.

The Council on Environmental Quality’s January 2025 timeline report puts the cross-agency median Notice-of-Intent-to-final-EIS duration at 2.5 years in 2023 (33% completed within two years) and 2.2 years in 2024 (41% within two years). Heavy-review categories take longer: Clean Air Task Force Senate testimony reports electric-transmission EIS review averaged 4.3 years (median 3.7 years), with the largest lines (over 100 miles, 345 kV) averaging 4.7 years. CEQ’s 2020 NEPA rulemaking materials separately stated that Federal Highway Administration EISs averaged over seven years notice-of-intent to record-of-decision; that figure uses a different methodology than the 2025 cross-agency report and predates the 2020 reform attempt. The 2023 Fiscal Responsibility Act introduced page limits, one-year EA and two-year EIS deadlines, applicant-prepared EAs/EISs under agency supervision, and a narrow right for project sponsors to seek a court-set schedule when agencies miss statutory deadlines. Recent CEQ data show improvement; the specific effects of the new statutory deadlines will take more time to evaluate. The central question — what share of remaining delay is over-binding rather than capacity starvation, mandate conflict, or litigation strategy — is contested, and §IV partitions it.

Each procedural element NEPA imposes tracks a real environmental-review function: information production, interagency coordination, public participation, alternatives analysis, environmental justice, reviewability. Many are individually defensible, and the protected output is real — environmental harms averted, communities consulted, redesigns induced, environmental-justice corrections applied. The aggregate has also helped produce an infrastructure-deployment regime where federal funding can outrun the review pipeline for major projects, where agencies and developers spend significant per-project resources on consultants whose work product exists in part to survive litigation, and where institutional capacity selects for compliance and procedure-managing roles alongside engineering judgment. Both ledgers — protected environmental output, displaced action capacity — are real; Cancer is the diagnosis only where the second exceeds the first at the margin.

NEPA is not unique. The same architectural pattern recurs across public procurement, healthcare administration, asylum and migration adjudication, EU compliance regimes, university research administration, and the Finnish Public Procurement Act regime and 2022-2023 social-and-healthcare reform implementation. In each case, sequentially-justified binding constraints accumulate past a capacity floor; in each case the institution enters paralysis, procedural substitution, exit, or selection for procedure-managing roles; in each case the standard repair (more procedure or less procedure) misses the structural question.

Where over-binding is the binding constraint, the conversion-failure reflex (add more binding) makes the system worse; where over-binding is not the binding constraint, applying the Cancer diagnosis without the §IV partition is itself a wrong repair.

II. The paired failure family

Conversion failure and Cancer failure are paired claims. Each conversion-failure diagnostic has a Cancer counterpart that describes the opposite limit of the same dimension.

The relevant capacity is not only institutional throughput; it is total error-adjusted burden across the institution and the affected parties. Cancer is what happens when binding mass exceeds that total — including the share that gets externalised onto claimants, patients, communities, applicants, and project beneficiaries when the institution speeds itself up by cutting corners.

Cancer failures begin where accumulated binding load dominates the next missing primitive. Each additional response duty, appeal right, documentation requirement, consultation step, audit trail, or review gate consumes more capacity than the institution can maintain while still acting.

Many real institutions exhibit both pathologies simultaneously on different dimensions or in different decision classes. An asylum authority may under-convert credible claims into adjudicated closure (conversion failure) while over-binding each procedural step on individual cases (Cancer). A healthcare provider may over-document patient encounters while failing to convert outcome feedback into care redesign. The paired diagnostics complement rather than exclude; the analytic move is to identify which pathology dominates the case at hand.

III. The mechanism

Cancer failures emerge through a repeatable sequence in mature institutional environments.

A failure occurs. A reform installs new procedural constraints: a new consultation requirement, a new impact assessment, a new oversight body, a new evidentiary threshold, a new appeal route, a new reasons duty, a new tracking ledger. Each constraint tracks a real prior failure — installed because the absence of the constraint produced the failure that justified the reform.

The reform compounds with previous reforms. A decision that satisfied three constraints now satisfies four. Then five. Then twelve. Each constraint imposes documentation, analysis, consultation, response, appeal, audit, and recordation. Each generates its own procedural object class, response duty, and contestability infrastructure. The compounding is structural: each rule has a defending constituency, and cumulative binding mass has no owner.

Cancer is the ratio between binding mass and action capacity, not a count of rules.

At some point the marginal cost of satisfying every constraint exceeds the value of making the decision. The institution adapts in one of four ways.

Action paralysis. Decisions are deferred, postponed, referred for further analysis, sent to committee, returned for additional consultation. NEPA EIS timelines reaching 4–7 years for major infrastructure categories; UK asylum-system backlog cycling between initial-decision queues and tribunal queues; UK Crown Court median offence-to-completion at 350 days in Q3 2025 (vs 254 in Q4 2019) are visible manifestations.

Procedural substitution. The institution performs every procedural move; substantive work hollows out. Impact assessments copy each other; consultations receive formulaic answers; response duties are met with template language; quality metrics improve while measured outcomes degrade. Michael Power’s Audit Society named this for verification regimes; the pattern recurs wherever cumulative procedural burden exceeds the institution’s capacity to attend substantively.

Exit and evasion. Substantive work routes around the formal system. Work moves to consultants, vendors, “pilot” labels, public-private shells, less-regulated entities, contractor systems, or jurisdictions with lighter requirements. Staff exit to the private sector. Decisions are made through informal pre-clearance channels; ephemeral messaging substitutes for recorded deliberation (see The Record Gate). The institution may continue to produce process while substantive activity migrates elsewhere.

Selection for compliance and procedure-managing roles. Career advancement depends on surviving audits, committees, accreditors, and litigation risk. Substantive experts either become paperwork managers or leave. In the optimistic version, compliance specialists rise. In the darker version, the institution loses both substantive and procedural expertise and ends up staffed by generalist managers, rotating consultants, external counsel, and exhausted frontline staff who know neither the domain nor the rules deeply enough to exercise judgment.

The four adaptations typically combine. The same institution can defer some decisions, simulate compliance on others, route critical work to vendors, and promote compliance specialists across the board.

The burden does not vanish under any of these adaptations; it conserves. When the Home Office accelerates initial asylum decisions and a lower grant rate sends more refused cases into appeal, error-correction load moves into the First-tier Tribunal queue, and the cost of being wrongly refused — destabilised housing, legal-aid scarcity, the risk of removal — falls on the claimant. When a hospital cuts documentation time, missed care-transitions, contraindication errors, and denial-appeal load shift onto patients. When NEPA review is shortened by categorical exclusion, undocumented harms fall on the communities the review was meant to inform. A Cancer diagnosis that tracks only institutional burden, and not the burden affected parties absorb when the institution speeds up, is doing one-sided accounting. The diagnostic question is total burden across institution and affected parties, not throughput at the institutional gate.

Three amplifiers make the accumulation durable: irreversibility, role selection, and asymmetric political economy.

The compliance industrial complex. Consultants, legal advisers, software vendors, certifiers, auditors, accreditation bodies, and training providers become structural beneficiaries of complexity. Their growth feeds back: every new compliance regime supports a new advisory market, whose continued existence depends on the regime’s persistence and ideally its expansion.

Incumbent advantage. Large firms and large institutions absorb compliance through fixed-cost departments and gain a moat. Small entrants are filtered out at the compliance gate. Cumulative procedural burden converts to market concentration without any actor having designed it for that purpose.

Asymmetric political economy. Every individual rule has a defending constituency (the actors it protects, the staff it employs, the precedent it sets). Cumulative burden has no defending constituency. Removal is politically attributable — the next bad event after a rule is removed is blamed on the remover — while accumulation is diffuse and produces no immediate adverse event. The political pricing is structurally asymmetric.

IV. Worked specimen: NEPA infrastructure permitting

NEPA is the cleanest lead specimen because its formal constraints are public-regarding and sequential, and its dominant private-rent confound is weaker than in healthcare or procurement. It is not pure. Capacity limits at agencies, litigation incentives across opposed coalitions, mandate conflict (climate goals against project-funding deadlines), and political vetoes are all present and have to be separated before the Cancer residual is named. The Cancer claim for NEPA is the residual after capacity starvation, litigation strategy, mandate conflict, capture, political underfunding, and incompetence are carved out — not raw permit delay.

Five decades of accumulation produced the current state. The original 1970 Act required federal agencies to assess environmental impacts of major actions and prepare environmental impact statements where impacts were significant. Implementing regulations and case law since added: alternatives analysis with reasonably comparable depth; cumulative impacts including downstream and indirect effects; mitigation measure analysis; programmatic review for related actions; cooperating agency requirements; scoping; public comment and response requirements under NEPA and agency procedures (and, in adjacent APA rulemaking doctrine, reasoned-response duties exemplified by Nova Scotia, State Farm, and Ohio v. EPA); environmental justice review; consultation under Endangered Species Act §7, National Historic Preservation Act §106, Clean Water Act §404; reasonable foreseeability standards for greenhouse gas analysis; judicial review under the Administrative Procedure Act with extensive litigation around scope, methodology, and procedural completeness. Many additions responded to specific prior failures or interpretive gaps. Each tracks a real environmental-protection function. The aggregate has helped produce an infrastructure-permitting regime where federal funding can outrun the review pipeline for many major projects.

California’s mini-NEPA, CEQA, is a contested concentrated echo. CEQA standing is broad: mandamus petitioners must generally be beneficially interested, but California courts also recognize public-interest standing, so challengers need not be environmental organizations or project neighbors. Critics such as Holland & Knight / Hernandez argue that CEQA litigation often targets housing, public-service infrastructure, and agency plans: their longitudinal analysis reported that the top three categories — residential, public-service/infrastructure, and agency-related projects — rose to about 59% of CEQA lawsuits in 2013-2015, with housing the top private-project target in later 2018 and 2019-2021 analyses; separate findings emphasize infill and transit-adjacent housing impacts. Defenders dispute the scale and causal interpretation. Broad litigation standing combined with procedural-completeness duties can generate binding mass around project delivery, including delivery of the housing density and transit infrastructure that the underlying environmental goals require.

The post-2023 reform attempts illustrate the asymmetric political economy. The Fiscal Responsibility Act introduced page limits, deadlines, lead-agency rules, and a narrow right for project sponsors to seek a court-set schedule when agencies miss deadlines. The 2024 Loper Bright decision overruled Chevron deference and required courts to exercise independent judgment on statutory interpretation; the inference (not the holding) is that agencies facing independent statutory review have stronger incentives to over-document their statutory and factual bases. The 2025 Seven County Infrastructure Coalition v. Eagle County decision cuts the other way for NEPA specifically — it granted agencies substantial deference on EIS scope and limited judicial review of separate upstream and downstream effects, reducing one specific driver of NEPA defensive documentation. The doctrinal environment is mixed: independent statutory review pushes documentation up, NEPA-specific deference pulls one component back down. The Cancer claim does not rest on doctrinal trajectory either way; it rests on aggregate maintenance burden built up over five decades.

Reform that targets the binding accumulation runs into the constituencies defending each individual binding; reform that targets the adjudicative architecture runs into the constituencies defending review rights. The pathology is structural, not factional.

Boundary-condition partition of NEPA dysfunction. Naming a share of NEPA delay as Cancer requires pricing the alternatives first:

• Capacity starvation: CEQ, agency NEPA staffs, and Interior solicitors are under-resourced relative to project volume; some delay is staff shortage, not procedural overhang.
• Mandate fragmentation: agencies authorise projects under one statute while satisfying conflicting commands under ESA, NHPA, and CWA.
• Litigation strategy: opponents of specific projects (anti-housing in CEQA, anti-fossil and pro-fossil litigants nationally) use procedural rights as delay weapons; this explains a meaningful share.
• Capture / political refusal to fund review: a Congress that authorises projects without funding the review infrastructure to permit them generates delay that is political, not procedural.
• Incompetence: ordinary administrative variance.

The Cancer residual is what survives the deduction: agencies, courts, and developers facing more binding obligations than the system’s combined action capacity can satisfy on the authorised timelines, even where staff are adequate, mandates compatible, opposing litigation absent, and competence intact. The residual is not the whole pathology, but it is structural rather than factional. The other components belong to other primitives — Dominant-Player Constraint for capture, capability architecture for capacity starvation, Refusal to Compute for mandate fragmentation.

The four diagnostic features appear in the NEPA case, though each is mixed with the boundary-condition pathologies the partition above carves out. Paralysis: cross-agency median EIS timelines above 2 years; project categories at 4–7+ years; some share is over-binding residual, much is capacity-starvation and litigation strategy. Procedural substitution: defensive record-construction partly oriented to surviving litigation rather than maximising substantive informational value, especially after Loper Bright. Exit: federal infrastructure activity routes through categorical exclusions, expedited review categories, and (where available) state or local processes. Compliance-role selection: NEPA-compliance careers are well-defined and structurally durable; substantive engineering and environmental-science judgment increasingly operates through them rather than alongside them. None of these is exclusive to Cancer (each appears in pure capacity-starvation cases too); their co-occurrence at the residual after partition is the Cancer signature.

NEPA is a clean specimen because the individual functions are real and the pathology is not that those functions are fake. It is that their cumulative maintenance burden, after the partition above, can exceed deployment capacity.

V. Echoes

The same architectural pattern recurs across several domains, each isolating one Cancer form and one confound:

EU regulatory accumulation. Compliance-surface overload across overlapping cross-cutting regimes — CSRD, CSDDD, DSA, DMA, GDPR, AI Act. The Commission’s simplification programme targets a 25% admin-burden cut for businesses and 35% for SMEs, with €37.5bn in savings projected by 2029; Draghi’s 2024 competitiveness report names regulatory complexity as one drag among several. Confounds: Commission self-interest in measurement framing; act-count methodology contested; member-state political variance.

Public procurement. Strategic-objective layering and defensibility-driven delay. The UK Procurement Act 2023 had its commencement deferred from 28 October 2024 to 24 February 2025 to produce a revised National Procurement Policy Statement. Confound: post-election policy change is a political fact, not procedural pathology in itself.

Healthcare administration. Mixed-architecture documentation and prior-authorisation load. Sinsky et al. (Annals of Internal Medicine, 2016) studied 57 physicians across four specialties: 27% of time on direct clinical care, 49% on EHR and desk work. The CMS Interoperability and Prior Authorization final rule (CMS-0057-F) sets 72-hour expedited and seven-calendar-day standard payer-response timelines from January 2026, with API requirements from January 2027 — regulation that compresses private rent friction, the architectural-reform face of healthcare’s burden problem. Confound: US healthcare’s procedural burden mixes sincere over-binding with insurer rent extraction operating through procedural friction; pure Cancer applies only after the capture component is separated. This is the visceral mixed case, not the lead.

UK asylum adjudication. Burden conservation across stages; the cost of being wrongly refused is absorbed by the claimant. Initial-decision backlog approximately 49,000 by end-2025; appeals backlog approximately 80,000; 108,000 initial decisions in 2025 (a 63% increase on 2024); asylum-system spending £4.8bn in fiscal year 2024/25 (Migration Observatory). Confounds: capacity starvation, hostile-environment political design, and refusal-rate volatility explain a large share before any Cancer residual; appeal rights are non-refoulement infrastructure, not throughput friction.

Universities and research administration. Selection for managerial and procedure-managing capacity. UK HESA data across 117 universities (LSE Impact Blog analysis): managers and non-academic professionals rose from just under 32,000 in 2005/06 to almost 51,000 by 2017/18 — roughly 60% growth; teaching-only staff grew over 80% between 2005/06 and 2018/19. Confounds: student services and welfare workers, careers advisers, satisfaction-data and regulatory-data demand, competition for students, REF/rankings incentives, and centralisation. Cancer is one input among several and probably not the dominant one in any single year.

VI. What does not work, and what does

Four repairs typically make the aggregate burden worse.

“Cut regulation.” The deregulatory response treats Cancer as evidence that the constraints were never legitimate. Each constraint was installed in response to a real failure; the constituencies that defended each constraint still exist; the original failures will recur if the constraint is removed without addressing the underlying problem. Deregulation runs into the same conversion-failure problem the binding was installed to address.

“Better coordination.” The technocratic response adds an oversight body or coordination mechanism to harmonise existing constraints. The new body acquires its own procedural requirements, response duties, and appeal route. The coordination layer adds binding mass without retiring any older binding; the aggregate burden rises.

“Automate compliance.” The technological response uses software, AI, or automated compliance platforms to reduce per-decision compliance cost. This can succeed at the per-artifact margin while accelerating procedural substitution: the institution produces compliance output efficiently while substantive work continues to atrophy.

“More staff.” The resource response funds additional positions to absorb the burden. This works when the added staff expand substantive capacity. It fails when added staff are themselves absorbed into compliance work, growing the compliance industrial complex inside the institution.

The repairs that target Cancer rather than its symptoms have three shapes — triage, architectural reform, and conditional closure with named corrective ownership. The menu is recognisably adjacent to the burden-reduction tradition (sunset clauses, regulatory PAYGO, permit-by-rule, safe harbors, post-hoc correction over ex ante review), but the corpus version is non-negotiable on three points: symmetric Self-Audit (removals must show that protected harm has not migrated to affected parties), funded-and-named corrective capacity, and total-burden accounting across institution plus affected parties. A safe-harbor that replaces ex ante review with a “monitoring framework” without statutory duty, budget, named owner, or reporting requirement is deregulation with the vocabulary stapled on; where the repair triple lacks the funded-corrective-ownership backstop, the constraint has been relabelled, not retired.

Triage of constraints. Some existing constraints have to be retired, merged, downgraded, or sunset at the level where the burden is actually produced. Broad numerical burden-budget regimes attempt this from above and routinely fail through scope exclusions, phantom savings, definitional gaming, and meta-Cancer overhead — the burden-budget machinery becomes its own administrative-burden generator.

The institutional record is sobering. US EO 13771 (“two-for-one”) was widely gamed through definitional asymmetry between major regulatory actions and minor deregulatory housekeeping (the 22-to-1 ratio was largely statistical illusion) and was revoked in January 2021. The UK Business Impact Target hit its £10bn target on paper by excluding £8.3bn of regulatory cost from scope while including only £0.9bn of savings, per NAO’s 2016 audit. The German Bürokratieentlastungsgesetz IV (2024) claimed €944m of annual savings with €625m of that from shortening a document-retention requirement from 10 to 8 years — other statutes still require 10 years for the same documents. Better Regulation administrative machinery in the UK costs ~£4.1m + ~£2.3m in departmental units annually, meta-Cancer overhead imposed to manage the accounting. Hard sunsets have worked in narrow cases of sector-specific economic deregulation (CAB Sunset Act 1984, ICC Termination Act 1995) where political consensus had matured and the legislature knew exactly what it was sunsetting; they do not generalise to safety, environmental, or public-health regulation where harms are diffuse. Triage works at the level of specific constraints where the burden is named and the protection it provides is also named, not at the level of aggregate cost ledgers across whole regulatory corpora.

Architectural reform. Replace artifact-by-artifact constraints with class-level rules only where the class-level rule preserves the protection. European administrative law’s proportionality doctrine attempts this at the substantive level; standardised technical assessments (rather than bespoke per-project assessments) attempt it at the procedural level. Architectural reform is harder than it looks because the specific protections each sector-specific constraint provided do not transfer cleanly to a general principle; the reform either loses protections or fails to reduce burden.

Conditional closure with named corrective ownership. Shift some burden from pre-decision perfection to post-decision correction, but only where Corrective Closure Ownership (CCO) actually exists: a named corrective owner with resourced capacity, independent verification, monitoring trigger, re-entry-and-repair authority, and public record and reporting duty. The lesson from broad burden-budget regimes is that aggregate ledgers fail without per-decision corrective ownership: removing constraints without naming who repairs the resulting harms is deregulation-without-correction, which exports burden to affected parties rather than removing it. CCO is the repair Cancer’s diagnosis points toward precisely because it operates at the per-decision level the aggregate ledgers cannot reach, and it makes the constraint-removal trade visible (the burden-budget gaming patterns rely on the constraint-removal trade being invisible). The full architecture is in Corrective Closure Ownership; the wrong-repair pattern this section warns against is removing constraints via aggregate budget without installing CCO at the level the constraint actually operates.

VII. The capacity floor and the theoretical lineage

Institutional action capacity is a bounded stock, not an unlimited resource. Two terms make the claim operational.

Action capacity is the budget, time, staff, expertise, attention, legal room, and decision bandwidth available for substantive action after mandatory process costs are paid.

Binding mass is the aggregate of duties to document, consult, analyse, respond, justify, appeal, report, verify, and preserve.

The Cancer threshold is the point at which an added binding obligation predictably reduces useful decision throughput or error-adjusted institutional output (including the burden absorbed by affected parties) by more than it improves protection. Below the threshold, additional binding produces additional protection at acceptable total cost. Above it, additional binding consumes capacity faster than it produces protection; the system protects itself out of the ability to act, and the residual error-correction load shifts onto the parties least equipped to carry it. The threshold is not a knife-edge or a quantitative index; it is a directional claim about the marginal trade. The operational handles are observable in principle: staff hours per decision, decision cycle time, process-FTE share, documentation volume per artefact, rework and appeal rates, consultant spend, decision throughput, error-correction capacity. Operationalising any one of them for a specific institution is a separate research task. The “Cancer residual” is the share of observed dysfunction that survives independent measurement of each named confound (capture, capacity starvation, mandate fragmentation, litigation strategy, incompetence) — not a rhetorical device for keeping an anti-procedure claim alive after every concrete confound has been admitted. Until the confounds are independently measured, the Cancer residual is a hypothesis; the NEPA partition in §IV sketches the form of that measurement, not a quantified result.

A worked NEPA example clarifies what the threshold is and is not. Suppose CEQ adds an additional environmental-justice impact analysis duty to EIS preparation. The protection added: more systematic accounting of disparate impacts on disadvantaged communities (real, non-trivial, and historically under-counted). The process costs added (hypothetical cost vector, not measured): additional EIS preparation time, additional consultant spend per project, additional litigation surface where the new analysis is alleged inadequate, defensive over-documentation as agencies attempt to inoculate the new section against challenge. The marginal trade is favourable when the underlying projects systematically generate disparate impacts the prior process missed and the new analysis materially reduces those impacts. It is unfavourable when the analysis becomes formulaic, projects are redesigned for litigation defensibility rather than substantive equity, and the projects most likely to be delayed (transit, infill housing, renewable transmission) are themselves disparate-impact-reducing. The Cancer threshold for this specific duty is whether the protection gained at the margin exceeds the protection lost by displacement of high-equity projects. Empirically determining the answer is hard, requires independent measurement of each named confound, and is not done here; conceptually the test is well-formed and falsifiable in principle.

The discipline this enforces: any new binding obligation must either retire an older binding, expand action capacity, enable triage that lets older bindings apply at class level rather than artifact level, or replace pre-decision burden with corrective ownership. The corpus’s existing primitives address conversion failures by adding binding mass; the discipline that prevents the corpus from contributing to the pathology it diagnoses is to ask, for any new primitive, what binding mass it adds, what burden it removes or reduces in exchange, what capacity it expands, and what triage it enables.

This is the institutional-governance application of the framework’s Cancer Constraint as formalised in Flourishing Is Maximum Safety Margin: when dC_min/dC > 1 — when marginal maintenance exceeds marginal capability — growth becomes fatal. The flourishing essay names the same condition at civilizational scale as “bureaucratic cancer” and “bureaucratic metastasis”; this essay names the institutional-mechanism counterpart. The Aliveness Inequality is the formal frame; “action capacity” and “binding mass” operationalise the same ratio at institutional scale, without claiming the operational claim is empirically proven by the formal one.

Theoretical lineage

Adjacent literatures already map parts of Cancer; none supplies the paired conversion-failure diagnostic or the symmetric self-audit.

Mancur Olson, The Rise and Decline of Nations (Yale, 1982) and The Logic of Collective Action (Harvard, 1965), names institutional sclerosis through accumulating distributional coalitions whose individual interests block adaptation. Olson’s account already covers cumulative asymmetry — concentrated defenders for each accretion, diffuse losers from total sclerosis, weak incentives to oppose any one element — so Cancer is not “beyond Olson”; it is a diagnostic partition inside Olsonian political economy, separating the origin mechanism (where the constraint came from: sincere prior failure vs coalition entrenchment vs litigation strategy) from the persistence mechanism (why nobody owns aggregate burden once it accumulates). The persistence mechanism is Olsonian. The origin partition is the corpus contribution, and it does not bracket capture so much as require it to be separately priced.

Brink Lindsey and Steven Teles, The Captured Economy (Oxford, 2017), name regulation as upward redistribution. Cancer Failure overlaps where capture and accumulation produce the same operational signature.

Francis Fukuyama, Political Order and Political Decay (FSG, 2014), names vetocracy and institutional decay. Cancer Failure’s mechanism is one micro-mechanism by which vetocracy operates; Fukuyama supplies the macro-decay frame, Cancer supplies the per-institution mechanism.

Michael Power, The Audit Society (Oxford, 1997), names ritualistic verification — compliance theatre that substitutes for substantive function. Power’s account already travels beyond narrow audit into performative assurance, second-order control, ritual accountability, and displacement of substantive work. Cancer adds the system-condition formalism: Power names ritualized verification at the regime level; Cancer names the institutional condition in which any binding device, audit or not, crosses the capacity floor when accumulated. The capacity-threshold model and total-burden accounting (institution plus affected parties) is Cancer’s contribution beyond Power; without those, “Cancer” is Power’s audit society relabeled.

Cass Sunstein, Simpler: The Future of Government (Simon & Schuster, 2013) and successor work, names regulatory complexity as governance pathology. Cancer adds the failure-family vocabulary and the corpus-internal pair against conversion failure.

Christopher Hood on blame avoidance and administrative control; Barry Bozeman on red tape (the distinction between functional rule burden and red tape as dysfunctional burden); Pamela Herd and Donald Moynihan, Administrative Burden: Policymaking by Other Means (Russell Sage, 2018) and the follow-up Herd-Moynihan-Widman 2024 Administrative Law Review synthesis, on administrative burden as policy design — all map adjacent territory. Cancer’s actual distinction is the focus and the accounting unit: Herd/Moynihan primarily analyze the burdens on people accessing public goods and rights; Cancer analyzes aggregate binding mass as an institutional action-capacity failure, while requiring affected-party burden to remain in the accounting. The two are complements operating on the same political-economy substrate from opposite sides of the gate.

Peter Schuck, Why Government Fails So Often (Princeton, 2014), is the closest single-volume adjacent account to Cancer’s diagnostic territory — legalism, incentive misalignment, competence limits, and institutional structure as recurrent failure-producers. Cancer’s contribution beyond Schuck is the failure-family pair against conversion failure and the corpus-internal repair architecture. Steven Vogel, Freer Markets, More Rules (Cornell, 1996), is essential context for the point that “market liberalization” routinely increases rule density rather than decreasing it. Daniel Carpenter on regulatory capture mechanism (especially the cultural-capture distinction from material capture) supplies the capture-pricing the boundary-condition partition requires.

Marc Dunkelman, recent infrastructure-paralysis writing, is a close parallel and precursor for the NEPA lead specimen. Ezra Klein and Derek Thompson, Abundance (Avid Reader Press / Simon & Schuster, 2025), supplies the public-facing political framing for Cancer’s territory — rules installed in earlier generations becoming blockers in later ones, government unable to act consequentially. Cancer’s narrower contributions are the diagnostic pair against conversion failure, the affected-party burden accounting, the corrective-closure repair architecture, and the Self-Audit discipline applied symmetrically to addition and removal.

Robert Kagan, Adversarial Legalism: The American Way of Law (Harvard, 2001), names the comparative claim load-bearing in §IV: American governance substitutes adversarial legalism and private litigation for more centralized bureaucratic administration, which is why NEPA’s litigation-as-contestability architecture generates the binding mass it does. Nicholas Bagley’s “procedure fetish” (Michigan Law Review 118:3) names the upstream loop Cancer’s mechanism in §III depends on: legitimacy-via-process logic motivates additional procedural constraint, which Cancer then accumulates past capacity.

The vocabulary blocks additive repair where over-binding is already the binding constraint, pairs the conversion-failure diagnosis with its over-binding counterpart, anchors the triage / architectural-reform / conditional-closure repair triple, and bridges to the Aliveness Inequality. It is not novel political economy; it is a corpus-internal diagnostic that prevents the conversion-failure-only analytic move from defaulting to additive accumulation.

VIII. Boundary conditions

Cancer Failure is one failure family. It does not subsume the others; misidentifying which family is active in a given case produces wrong repairs that worsen the actual problem.

Cancer is the residual after capture, capacity starvation, mandate fragmentation, litigation strategy, and incompetence are priced. Each is a distinct pathology with a distinct repair:

Capture (rent extraction by privileged actors who shape the rules in their favour): the binding mass exists because specific beneficiaries installed it. The repair is anti-capture architecture (transparency, conflict-of-interest rules, dominant-player constraint design) rather than burden triage. Lindsey & Teles territory.

Capacity starvation (the institution lacks staff, budget, or technology to discharge a manageable burden): the binding mass is not the binding constraint; resource scarcity is. The repair is investment, not triage. Most asylum-system backlogs include large capacity-starvation components alongside any Cancer component.

Mandate fragmentation (the institution has incompatible mandates that cannot be simultaneously satisfied regardless of capacity): the burden is contradictory rather than aggregate. The repair is mandate reconciliation at the political level, not procedural triage.

Litigation strategy (third-party actors deliberately use procedural rights to delay, defeat, or extract concessions from decisions they oppose): the binding mass operates as a weapon. The repair targets the litigation-incentive structure rather than the procedural architecture itself.

Bureaucratic incompetence (the institution’s procedural design is straightforwardly bad on its own terms): no aggregation pathology required. The repair is competent design.

The diagnostic discipline: before naming a case Cancer, separate the capture / capacity-starvation / mandate-fragmentation / litigation-strategy / incompetence components, identify how much of the observed dysfunction those alternatives explain, and name as Cancer only the residual that survives. In practice most large cases combine several pathologies; the diagnostic value is partitioning the dysfunction rather than absorbing all of it into a single family.

Cancer complements rather than substitutes for the conversion-failure primitives. Many institutions exhibit both pathologies simultaneously on different dimensions. The conversion-failure repair (more binding) is correct where under-binding is the binding constraint; the Cancer repair (triage, architectural reform, conditional closure) is correct where over-binding is. The repair follows the active constraint in the case at hand.

The opposite of Cancer is not unbound discretion. It is healthy binding: constraints whose marginal correction value, summed across institutional capacity preserved and affected-party protection extended, exceeds their marginal maintenance cost, and whose cumulative burden has a named owner. Most binding most of the time is healthy. Cancer is what happens when the conditions for healthy binding fail at the aggregate even though each constituent rule still satisfies them locally.

The Cancer Self-Audit

A proposed new constraint passes the Cancer Self-Audit only if it identifies at least one of: burden retired, burden merged, capacity expanded, triage improved, or pre-decision burden replaced by corrective ownership. A constraint that adds binding mass without any of these contributes to the pathology it would otherwise help diagnose.

The audit is symmetric. A proposed removal, downgrading, merging, or sunset of an existing constraint must show that the protected harm has not migrated, that substitute protection is real and funded, and that affected parties are not absorbing the cost the institution is shedding. Constraint removal without those showings exports binding mass to the people the constraint was supposed to protect — which is the inverse Cancer the institution-centred audit alone misses.

Screening rule. The Cancer partition is run where the proposed repair adds binding mass, or where delay, procedural substitution, exit, or compliance-role selection is already a visible symptom. Running it on cases where over-binding is plainly not the binding constraint would itself contribute to the pathology.

Sub-pathology routing. Cancer is an umbrella mechanism. Existing corpus primitives still own diagnostic specificity for the input routes, and a real case is usually routed through one of them before Cancer’s partition becomes the relevant frame:

The table is non-exhaustive and the cells are not exclusive — a single case can present multiple routes. Cancer’s partition operates after the route is identified, not before.

IX. Close

Cancer Failure is the cross-layer condition where locally justified bindings across the Stack aggregate beyond an institution’s capacity to act. It is not another Stack layer; it is the system-level overload condition that can arise from too many repairs to existing Stack layers. Its operational forms are paralysis, procedural substitution, exit and evasion, and selection for compliance roles; its repair triple is triage of constraints, architectural reform, and conditional closure with reopening capacity. Its diagnostic discipline is to separate capture, capacity starvation, mandate fragmentation, litigation strategy, and incompetence before attributing dysfunction to over-binding alone.

The conversion-failure primitives repair under-binding; Cancer repairs over-binding (including the burden externalised onto affected parties). The pair’s discipline — symmetric Self-Audit, sub-pathology routing, screening rule — prevents the over-binding diagnosis from collapsing into a deregulatory default.

Cancer completes the diagnostic pair. Conversion failure asks what needed binding is missing. Cancer asks when accumulated binding becomes the thing that blocks action. The repair is not more procedure or less procedure. It is triage, architectural simplification, and conditional closure with a named corrective owner.

Related corpus essays:

• Flourishing Is Maximum Safety Margin — formal Aliveness Inequality; “bureaucratic cancer” / “bureaucratic metastasis” at civilizational scale; dC_min/dC > 1 condition this essay specialises to institutions
• The Stack — twelve-layer failure taxonomy; Cancer sits cross-layer to it
• Corrective Closure Ownership — the conditional-closure-with-reopening architecture Cancer’s diagnosis points to as repair
• The Record Gate — over-recording is one specific input route into Cancer; Record Gate names per-gate architecture, Cancer names system-level aggregation
• Refusal to Compute — premature procedural fixation is a Cancer-adjacent pathology
• Implementation Ledger — downstream sibling; execution tracking of accepted commitments
• Feedback Authority — grades response duty once feedback arrives; Cancer is what happens when too many response duties accumulate
• Capability Architecture — capacity-side primitive